FMR1 Antikörper (AA 116-130)
Kurzübersicht für FMR1 Antikörper (AA 116-130) (ABIN570983)
Target
Alle FMR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- AA 116-130
-
Verwendungszweck
- FMR1 (aa116-130)
-
Sequenz
- NPNKPATKDT FHKIK
-
Kreuzreaktivität
- Human, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-NPNKPATKDTFHKIK, from the internal region of the protein sequence according to NP_002015.1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Brain (Cortex) and Placenta. Recommended concentration: 2.5 μg/mL.
Western Blot: Approx 70 kDa band observed in lysates of cell lines HeLa, Jurkat and Kelly (calculated MW of 71.2 kDa according to NP_002015.1). Recommended concentration: 0.3-1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:32000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- FMR1 (Fragile X Mental Retardation 1 (FMR1))
-
Andere Bezeichnung
- FMR1
-
Hintergrund
- FMR1, fragile X mental retardation 1, FMRP, FRAXA, MGC87458
-
Gen-ID
- 2332, 24948
-
NCBI Accession
- NP_002015
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Target
-